GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

A massive study of 700,000 medical records reveals that teenagers with cannabis use disorder face a 52% higher risk of schizophrenia compared to those using other substances.

GLP-1 receptor agonists were associated with reduced risk of alcohol, cannabis, cocaine, nicotine and opioid use disorders, as well as other substance use disorders, suggesting potential prevention ...

Gov. Gavin Newsom last week announced $1.18 billion in Bond Behavioral Health Continuum Infrastructure Program (BHCIP) awards, funding an additional 66 projects across 130 behavioral health facilities ...

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Iowa House lawmakers passed a bill making the plant-based stimulant kratom a Schedule I controlled substance. The bill now goes to the Senate.

Kentuckians deserve confidence that every public dollar invested in addiction treatment is spent wisely, transparently and in ...

For former NBA point guard Chris Herren, putting on a Boston Celtics jersey should have been the highlight of his career. Instead, he remembers it as one of the most painful moments of his life.“I had ...

A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use ...